Esbriet is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Intermune, Inc.. The primary component is Pirfenidone.
| Product ID | 64116-121_58cc9885-2828-435d-9db2-8e94cdecfa00 |
| NDC | 64116-121 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Esbriet |
| Generic Name | Pirfenidone |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-10-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022535 |
| Labeler Name | InterMune, Inc. |
| Substance Name | PIRFENIDONE |
| Active Ingredient Strength | 267 mg/1 |
| Pharm Classes | Pyridone [EPC],Pyridones [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2014-10-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022535 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-10-16 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA022535 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-10-16 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA022535 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-10-16 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PIRFENIDONE | 267 mg/1 |
| SPL SET ID: | 0ab861c2-d5ca-4f92-854c-6477971a1b38 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50242-121 | ESBRIET | PIRFENIDONE |
| 50242-122 | ESBRIET | PIRFENIDONE |
| 50242-123 | ESBRIET | PIRFENIDONE |
| 64116-121 | Esbriet | Esbriet |
| 0480-3610 | Pirfenidone | Pirfenidone |
| 0480-3611 | Pirfenidone | Pirfenidone |
| 0781-2158 | Pirfenidone | Pirfenidone |
| 0781-8085 | Pirfenidone | Pirfenidone |
| 0781-8086 | Pirfenidone | Pirfenidone |
| 16729-467 | PIRFENIDONE | PIRFENIDONE |
| 16729-468 | PIRFENIDONE | PIRFENIDONE |
| 31722-872 | Pirfenidone | Pirfenidone |
| 31722-873 | Pirfenidone | Pirfenidone |
| 42385-923 | Pirfenidone | Pirfenidone |
| 42385-924 | Pirfenidone | Pirfenidone |
| 42385-925 | Pirfenidone | Pirfenidone |
| 42385-926 | Pirfenidone | Pirfenidone |
| 42571-335 | Pirfenidone | Pirfenidone |
| 42571-336 | Pirfenidone | Pirfenidone |
| 50228-441 | PIRFENIDONE | PIRFENIDONE |
| 50228-442 | PIRFENIDONE | PIRFENIDONE |
| 50228-443 | PIRFENIDONE | PIRFENIDONE |
| 60219-1640 | Pirfenidone | Pirfenidone |
| 60219-1641 | Pirfenidone | Pirfenidone |
| 60219-1642 | Pirfenidone | Pirfenidone |
| 62332-479 | Pirfenidone | Pirfenidone |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ESBRIET 86332703 4688507 Live/Registered |
GENENTECH, INC. 2014-07-09 |
![]() ESBRIET 77527761 4132175 Live/Registered |
GENENTECH, INC. 2008-07-21 |